RecruitingPhase 4NCT06507202

Comparison of Remimazolam and Propofol for Recovery of Ambulatory Upper Airway Surgery

Comparison of Remimazolam Versus Propofol-based General Anesthesia on Postoperative Quality of Recovery in Patients Undergoing Ambulatory Upper Airway Surgery: a Randomized Controlled Trial


Sponsor

Chung-Ang University Gwangmyeong Hospital

Enrollment

116 participants

Start Date

Jan 22, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to compare the effects of remimazolam and propofol on postoperative recovery time, complications, and safety in patients undergoing ambulatory upper airway surgery under general anesthesia.


Eligibility

Min Age: 19 Years

Inclusion Criteria2

  • Adult patients (age 19 or older) undergoing ambulatory upper respiratory tract (nasal cavity, oral cavity, pharynx, larynx) surgery under general anesthesia
  • American Society of Anesthesiologists physical class classification I, II, and III

Exclusion Criteria6

  • Patients who refused to participate in the study
  • Pregnant patients
  • Patients with a history of hypersensitivity to drugs or additives used during surgery
  • Patients with acute narrow-angle glaucoma
  • Alcohol or drug dependent patients
  • Patients with Child-Pugh class C liver dysfunction

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGRemimazolam

General anesthesia is induced and maintained by continuous infusion of remimazolam and remifentanil, and recovered with flumazenil.

DRUGPropofol

General anesthesia is induced and maintained by continuous infusion of propofol and remifentanil.


Locations(1)

ChungAng University Gwangmyeong Hospital

Gyeonggi-do, Gwangmyeon-si, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06507202


Related Trials